Epidemiology and outcomes of early-onset AKI in COVID-19-related ARDS in comparison with non-COVID-19-related ARDS: insights from two prospective global cohort studies.

Bairbre A McNicholasEmanuele RezoagliAndrew J SimpkinSankalp KhannaJacky Y SuenPauline YeungDaniel BrodieGianluigi Li BassiTai PhamGiacomo BellaniJohn F FraserJohn Laffeynull null

Published in: Critical care (London, England) (2023)

AKI is a common and serious complication of COVID-19, with a high mortality rate, which differs by geo-economic location. Important differences exist in the profile of AKI in COVID-19 versus non-COVID-19 ARDS in terms of their haemodynamic profile, time of onset and clinical outcomes.

Keyphrases

coronavirus disease
sars cov
early onset
acute kidney injury
acute respiratory distress syndrome
extracorporeal membrane oxygenation
mechanical ventilation
risk factors
late onset
cardiovascular disease
intensive care unit
metabolic syndrome
insulin resistance
drug induced